Physician profile
Jennifer E Brady
NPI 1639229313
$3,401.98
in general payments reported to CMS, 2019-2025
51 companies · $267 in 2025
The $267 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,659 · 2020: $314 · 2022: $156 · 2023: $271 · 2024: $735 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,273.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $319.65 | 2019-2025 | Repatha |
| Novartis Pharmaceuticals Corporation | $281.25 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $211.55 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $194.24 | 2019-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $189.50 | 2019-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $182.92 | 2019-2024 | |
| Pfizer INC. | $146.82 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $130.17 | 2019-2024 | |
| Avanir Pharmaceuticals, INC. | $109.43 | 2019 | |
| Ucb, INC. | $107.90 | 2019 | |
| Preventice Services, LLC | $105.16 | 2019 | |
| Acadia Pharmaceuticals INC | $104.31 | 2019-2020 | |
| Irhythm Technologies, INC. | $102.70 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Alexion Pharmaceuticals, INC. | $87.95 | 2019-2024 | Strensiq |
| Sunovion Pharmaceuticals INC. | $85.76 | 2019-2020 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Brady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.